Table 2.
Summary of lab-based studies for investigation and treatment of ischemia reperfusion injury on Ex Vivo Lung Perfusion
Agent/mechanism/modality | Target | Model | Experimental Groups (N) | Key points | |
---|---|---|---|---|---|
| |||||
Pharmacologic | |||||
| |||||
Wang 202042 | 3-aminobenzamide | Poly(adp-ribose) polymerase (PARP) | Murine | EVLP+PARP inhibitor (16); EVLP (15); Control (14) | EVLP+ PARP inhibitor has higher compliance; lower pulmonary edema; and lower LDH, IL-6, and IL-10. |
Lin 201845 | α1-antitrypsin (A1AT) | - | Porcine | EVLP (6);EVLP+A1AT (6) | Reduced pulmonary artery pressure, pulmonary vascular resistance, pulmonary edema, apoptosis and IL-1α & IL-8. |
Wang 201848 | Sevoflurane | - | Murine | EVLP+ Sevoflurane (6); EVLP (6); Baseline (3) | Reduced LDH, 3-nitrotyrosine, protein carbonyl, TNF-α, pulmonary edema. Increased oxygenation capacity and static pulmonary compliance. |
Weathington 201844 | BC1215 with Lipopolysaccharide stress test (LPS) | ubiquitin E3 ligase protein- FBXO3 | Human | EVLP+LPS+BC1215 (3); EVLP+ LPS(4) | BC1215 is associated with reduced NF-κβ associated transcripts and inflammatory cytokines. Improved oxygenation |
Hijiya 201747 | Inhaled β 2 agonist | β 2 adrenoreceptor | Canine | EVLP (5); EVLP+ β2 agonist (5) | Lower PVR, higher CAMP and ATP in β2 group |
Huerter 201640 | Selective A2BR blocker- ATL802 | adenosine A2B receptor (A2BR) | Murine | EVLP (9); EVLP+ATL802 (9) | ATL802 associated with reduced cytokine production, neutrophil infiltration, vascular permeability, and edema. Improved pulmonary compliance. |
Haam 201549 | Inhaled hydrogen | Oxidative pathways | Porcine | EVLP(5); EVLP+hydrogen(5) | Lower levels of IL-1β, IL-6, IL-8, TNF-α in the EVLP +hydrogen group |
Shaghaghi 201543 | Ascorbic acid | - | Murine | EVLP + Ascorbic acid (5);EVLP (5) | Total metabolite was signal larger in the ascorbate cohort and oxidative phosphorylation pathway was more active compared to control, suggesting improved mitochondrial function |
Stone 201539 | Adenosine 2A receptor agonist | Adenosine 2 A receptor (A2AR) | Murine | Cold static preservation (12); EVLP (12);EVLP+A2AR agonist (12) | Lung edema, cytokines IL-1, IL-8, IL-6, and IL-17) and neutrophil counts significantly lower in EVLP+A2AR compared with EVLP or cold static preservation. |
| |||||
Gene therapy/diagnostics | |||||
| |||||
Tan 202027 | Fusion protein (FP) targeted at 8-oxoguanine DNA glycosylase | Mitochronrial DNA | Murine | Native(11); Native+FP(13) ); DCD(7); DCD+FP (10); DCD+FPKO (8) | Higher fraction of intact mitochondrial DNA in DCD+FP group compared with DCD and knockout mice- associated with lower pulmonary edema and lower mitochondrial DAMPs. |
Lonati 201824 | Transcription factor analysis in Frozen lung biopsy specimens | - | Murine | Native (5) Pre-EVLP (5) Post-EVLP (5) |
EVLP modulates NF-kB,signal transducer and activator of transcription 3, ERK1/2, p38, Akt, and stress-activated protein kinase/JNK signaling pathways. Increased transcription of genes related to inflammation and its regulation, apoptosis/survival, heat shock, and oxidative stress response |
Rofia 201825 | Nano LC-MS spectrometry in frozen lung biopsy | - | Murine | Native(5); Pre-EVLP (5); Post-EVLP (5) | Increased expression of super oxide dismutase-1 associated with reduced free radical damage on EVLP |
Yeung 2018 26 | Gene expression profiles in frozen lung biopsy specimens | - | Human | n=10 | EVLP associated with increased gene expression for endothelial markers of inflammation. Decreased expression of leucocyte-specific genes. |
Machuca 201728 | Adenoviral vector(AV) for human IL10 gene delivery | Nuclear transcription machinery | Porcine | Cold ischemia (4); AV control (4); EVLP control (5); EVLP+AV (5) | Lower acute rejection score in EVLP+AV compared with EVLP; better gas exchange at 7 days. No significant difference in Il-1β, IL6, IL8, or IFNγ |
| |||||
Stem cell and immune therapy | |||||
| |||||
Lonati 201933 | Mesenchymal stem cell derived extracellular vesicles (EV) via perfusate | - | Murine | EVLP+EV (5); EVLP+ saline (5) | EVLP+EV had lower vascular resistance, higher perfusate nitric oxide metabolites, higher pulmonary ATP |
Andreasson 201731 | - | Cytokine levels and neutrophil adhesion | Human | N= 42 | Increased IL1β and TNFα associated with inpatient mortality |
Martens 201732 | Multipotent adult progenitor cells (MAPC) via airway | - | Porcine | EVLP+MAPC (6); EVLP+albumin (6) | No difference in physiological parameters between groups. Lower BAL neutrophils, TNF-α, IL-1β and IFN-γ in MAPC group. |
Noda 201730 | Leukofiltration (LF); caspase-1-inhibitor (INH) | Donor leukocytes, Caspase-1 | Murine | EVLP (5);EVLP+LF (5); EVLP+ release of filtered; cytokines (5); EVLP+INH (5) | Leukofiltration and caspase inhibitor associated with lower levels of IL6,TNFα and IL1β; 26% percent of filtered cells found to be pyroptotic. |
Stone 201629 | EVLP compared with standard lung transplant | Donor leukocytes | Porcine | EVLP (6); Control (6) | EVLP associated with reduced donor leucocyte transfer, allorecognition, T-cell priming and T-cell infiltration of recipient. |